The Bank of Korea will be conducting its retail central bank digital currency (CBDC) simulations involving at least ten commercial banks, including Shinhan Bank and NH Nonghyup Bank.
Examining user payments and remittances as part of testing with commercial banks will help to confirm interoperability between the CBDC and the financial institutions' IT systems.
BK just finished the first and second stages of its simulations of retail central bank digital currency (CBDC) and
It has been about a year since the Bank of Korea chose Ground X, the organization that created the Klaytn public permissioned blockchain, as its CBDC vendor. Klaytn and the permissioned CBDC blockchain are both based on Ethereum technology.
After finishing its investigation later this year, the central bank intends to release a report on the digital won.


Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Thailand Inflation Remains Negative for 10th Straight Month in January
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



